Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nick Freemantle

Showing results (291-300 of 300) with videos related to

Pageof 30
Sort By:
You have reached the last page of results.This site can display upto 300 results.
European Heart Journal|May 22, 2023
Conventional heart failure therapy in cardiac ATTR amyloidosisAdam Ioannou, Paolo Massa, Rishi K Patel, et al.
Research and Practice in Thrombosis and Haemostasis|August 14, 2024
Rivaroxaban for stroke patients with antiphospholipid syndrome (RISAPS): protocol for a randomized controlled, phase IIb proof-of-principle trialPrabal Mittal, Rafael Gafoor, Zara Sayar, et al.
Lancet (London, England)|November 4, 2024
Optimal timing of anticoagulation after acute ischaemic stroke with atrial fibrillation (OPTIMAS): a multicentre, blinded-endpoint, phase 4, randomised controlled trialDavid J Werring, Hakim-Moulay Dehbi, Norin Ahmed, et al.
Lancet (London, England)|June 26, 2025
Collaboration on the optimal timing of anticoagulation after ischaemic stroke and atrial fibrillation: a systematic review and prospective individual participant data meta-analysis of randomised controlled trials (CATALYST)Hakim-Moulay Dehbi, Urs Fischer, Signild Åsberg, et al.
The Lancet. Neurology|November 17, 2023
Classic ketogenic diet versus further antiseizure medicine in infants with drug-resistant epilepsy (KIWE): a UK, multicentre, open-label, randomised clinical trialNatasha E Schoeler, Louise Marston, Laura Lyons, et al.
Stroke|May 22, 2025
Anticoagulation Timing in Acute Stroke With Atrial Fibrillation According to Chronic Kidney Disease: The OPTIMAS TrialPhilip S Nash, Hakim-Moulay Dehbi, Norin Ahmed, et al.
BMJ Open|October 29, 2021
Surgical aortic valve replacement in the era of transcatheter aortic valve implantation: a review of the UK national databaseMarjan Jahangiri, Rajdeep Bilkhu, Andrew Embleton-Thirsk, et al.
International Journal of Stroke : Official Journal of the International Stroke Society|March 30, 2026
Early Versus Delayed Anticoagulation in Acute Ischaemic Stroke with Atrial Fibrillation According to Infarct Volume and Location: a Prespecified Subgroup Analysis of the OPTIMAS Randomised Controlled TrialPhilip S Nash, Jonathan Best, James Lyon, et al.
BMJ Open Respiratory Research|September 21, 2021
SARS-CoV-2 lineage B.1.1.7 is associated with greater disease severity among hospitalised women but not men: multicentre cohort studyOliver Stirrup, Florencia Boshier, Cristina Venturini, et al.
The Journal of Infection|October 5, 2021
The Alpha variant was not associated with excess nosocomial SARS-CoV-2 infection in a multi-centre UK hospital studyFlorencia A T Boshier, Cristina Venturini, Oliver Stirrup, et al.
Pageof 30

Showing results (291-300 of 300) with videos related to

Sort By:
Pageof 30
You have reached the last page of results.This site can display upto 300 results.
European Heart Journal|May 22, 2023
Conventional heart failure therapy in cardiac ATTR amyloidosisAdam Ioannou, Paolo Massa, Rishi K Patel, et al.
Research and Practice in Thrombosis and Haemostasis|August 14, 2024
Rivaroxaban for stroke patients with antiphospholipid syndrome (RISAPS): protocol for a randomized controlled, phase IIb proof-of-principle trialPrabal Mittal, Rafael Gafoor, Zara Sayar, et al.
Lancet (London, England)|November 4, 2024
Optimal timing of anticoagulation after acute ischaemic stroke with atrial fibrillation (OPTIMAS): a multicentre, blinded-endpoint, phase 4, randomised controlled trialDavid J Werring, Hakim-Moulay Dehbi, Norin Ahmed, et al.
Lancet (London, England)|June 26, 2025
Collaboration on the optimal timing of anticoagulation after ischaemic stroke and atrial fibrillation: a systematic review and prospective individual participant data meta-analysis of randomised controlled trials (CATALYST)Hakim-Moulay Dehbi, Urs Fischer, Signild Åsberg, et al.
The Lancet. Neurology|November 17, 2023
Classic ketogenic diet versus further antiseizure medicine in infants with drug-resistant epilepsy (KIWE): a UK, multicentre, open-label, randomised clinical trialNatasha E Schoeler, Louise Marston, Laura Lyons, et al.
Stroke|May 22, 2025
Anticoagulation Timing in Acute Stroke With Atrial Fibrillation According to Chronic Kidney Disease: The OPTIMAS TrialPhilip S Nash, Hakim-Moulay Dehbi, Norin Ahmed, et al.
BMJ Open|October 29, 2021
Surgical aortic valve replacement in the era of transcatheter aortic valve implantation: a review of the UK national databaseMarjan Jahangiri, Rajdeep Bilkhu, Andrew Embleton-Thirsk, et al.
International Journal of Stroke : Official Journal of the International Stroke Society|March 30, 2026
Early Versus Delayed Anticoagulation in Acute Ischaemic Stroke with Atrial Fibrillation According to Infarct Volume and Location: a Prespecified Subgroup Analysis of the OPTIMAS Randomised Controlled TrialPhilip S Nash, Jonathan Best, James Lyon, et al.
BMJ Open Respiratory Research|September 21, 2021
SARS-CoV-2 lineage B.1.1.7 is associated with greater disease severity among hospitalised women but not men: multicentre cohort studyOliver Stirrup, Florencia Boshier, Cristina Venturini, et al.
The Journal of Infection|October 5, 2021
The Alpha variant was not associated with excess nosocomial SARS-CoV-2 infection in a multi-centre UK hospital studyFlorencia A T Boshier, Cristina Venturini, Oliver Stirrup, et al.
Pageof 30